These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2862944)

  • 1. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dopexamine on the cardiovascular system of the dog.
    Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FPL 63012AR: a potent D1-receptor agonist.
    Smith GW; Farmer JB; Ince F; Matu K; Mitchell PD; Naya I; Springthorpe B
    Br J Pharmacol; 1990 Jun; 100(2):295-300. PubMed ID: 1974159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prolonged infusion of dopexamine on beta 1- and beta 2-adrenoceptors in guinea-pig myocardium.
    Williams DW; Elnatan J; Molenaar P; Summers RJ
    J Auton Pharmacol; 1990 Jun; 10(3):127-37. PubMed ID: 1974255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
    Smith GW; O'Connor SE
    Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
    Bass AS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.
    Ruffolo RR; Messick K; Horng JS
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):317-26. PubMed ID: 6090958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
    Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
    Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
    Fitton A; Benfield P
    Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
    Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Uptake1 by dopexamine hydrochloride in vitro.
    Mitchell PD; Smith GW; Wells E; West PA
    Br J Pharmacol; 1987 Oct; 92(2):265-70. PubMed ID: 2890392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
    Magrini F; Foulds R; Roberts N; Macchi G; Mondadori C; Zanchetti A
    Eur J Clin Pharmacol; 1987; 32(1):1-4. PubMed ID: 2884113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.
    Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
    Eur J Pharmacol; 1985 Dec; 118(3):321-9. PubMed ID: 2867915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopexamine hydrochloride on sympathetic neuroeffector transmission in rabbit isolated pulmonary artery.
    Nedergaard OA
    Pharmacol Toxicol; 1996 Mar; 78(3):161-6. PubMed ID: 8882349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
    Bass AS
    J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.